Dr. Kevin Zorn
Staff
Punctuality
Helpfulness
Knowledge
6900 Decarie Blvd Suite M265 , Suite M265
Montréal-Ouest, QC, Canada
H3X2T8
Facility Affiliations
Dr. Kevin Zorn's Credentials
Accepting New Patients
Yes, this doctor is accepting new patients
Biography
Email: URO@ROCKLANDMD.COM EMAIL: INFO@STEINBERGUROLOGY.COM EMAIL: INFO@BPHCANADA.COM WEBSITE: WWW.BPHCANADA.com PHONE: 514-443-0808 Dr. Kevin Zorn is a dual-board-certified (US and Canada), minimally-invasive urologist, oncology-fellowship trained at the University of Chicago. As a native Montrealer, Dr. Zorn received his undergraduate and MD degrees from McGill University where he completed his residency in urology. His main focus of clinical and scientific interest is in the surgical treatment of benign prostatic hyperplasia (BPH) and prostate cancer. Other than his focus on robotic surgery with over 2500 robotic prostatectomy cases performed, Dr. Zorn is also the national Canadian surgical trainer and international proctor for the Greenlight XPS 180W laser since 2012. He has also an active trainer from residents to international urologists with integration of simulation experience. He has also been an invited speaker/visiting professor for his academic work on laser therapies and techniques for BPH management. He was the first in Canada to utilize the latest version of the Greenlight 180W XPS laser for BPH and has pioneered an enucleation-like technique to standardize Greenlight technique. Not only has Dr. Zorn helped with the national BPH guidelines, he is also an active with various other minimally invasive therapies with Urolift, Rezum, Aquablation and other cutting edge technologies. Dr. Zorn is an active researcher and a dedicated teacher to his urology residents and fellows. He has published extensively on prostate surgical care with over 220 peer-reviewed papers and 12 book chapters (http://www.ncbi.nlm.nih.gov/pubmed?term=zorn%20kc). He has received awards for his clinical work, research and teaching from the AUA and Endourological Society. He is also a reviewer for many urological journals and has been awarded Best Reviewer for Prostate Cancer in 2009 and 2010 for the Journal of Urology. He has also been a member of the American Urological Association (AUA) educational task force for the development of the laparoscopic and robotic urologic surgery curriculum and has served AUA hands-on course director for the annual AUA annual meetings for 7 years. Dr. Zorn has also helped develop and organize the University of Chicago Robotic Radical Prostatectomy Course (a symposium of the world's top robotic surgeons) which began in 2007. He has worked closely with AMS/BSCI through center of excellence (COE) training activities to foster Greenlight XPS training. Most recently, he has been invited as a member of the CUA BPH Guidelines Committee as well as the CUA continuing professional development (CPD) Committee. As such, Dr. Zorn has a passion for academics and peer-related education. Moreover, to assist with urology learning, he has created the free-access website (www.intuitiveurology.com) to foster global urological education. He is also the urological leader of surgical simulation with the Centre Hopitalier de l’Universite de Montreal (CHUM) residency program, specifically for laparoscopy, robotic and laser prostate surgery. Over the past 8 years, Dr. Zorn has returned home to Montreal to develop the University of Montreal (CHUM) robotic and laser BPH program. He serves as Associate Professor of Surgery and Director of Robotic Surgery.
Languages
- Spanish
- German
- French
- English
Education
- McGill University (Grad. 2005)
- University of Chicago (Grad. 2007)
Areas of Expertise
- Transurethral resection of the prostate (TURP)
- Scrotal masses
- Hydrocele
- Hair loss
- Prostate laser surgery
- Hormone therapy for prostate cancer
- Prostate biopsy
- Vasectomy
- Benign prostatic hyperplasia (BPH)
- Active surveillance for prostate cancer
- Prostatectomy
Awards & Recognitions
- Director of BPHCanada Center of BPH Excellence
- Professor of Urology, Director of BPH and Robotic Surgery
Publications & Research
- How I Do It: Temporarily Implanted Nitinol Device (iTind)
- New Technologies for Treatment of Benign Prostatic Hyperplasia
- Rezūm water vapor therapy for catheter-dependent urinary retention: a real-world Canadian experience
- Patient Perspectives on Benign Prostatic Hyperplasia Surgery: A Focus on Sexual Health
- Aquablation Outcomes in Men With LUTS Due to BPH Following Single Versus Multi-pass Treatments
- Age-stratified continence outcomes of robotic-assisted radical prostatectomy
- Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons
- Large, Multi-Center, Prospective Registry of Rezūm Water Vapor Therapy for Benign Prostatic Hyperplasia
- Reasons to overthrow TURP: bring on Aquablation
- Is it time to offer True Minimally Invasive Treatments (TMIST) for BPH? - A review of office-based therapies and introduction of a new technology category
- Functional and surgical outcomes of Aquablation in elderly men
- Canadian Urological Association BPH 2022 Guidelines
- Rezūm therapy for ≥80-mL benign prostatic enlargement: a large, multicentre cohort study
- Transfusion rates after 800 Aquablation procedures using various haemostasis methods
I met with Dr. Zorn in January 2024 for a consultation. After discussing my urine retention issue due to BPH and a possible mitigation strategy, I decided to undergo an aquablation procedure. As a scientist, I did my due diligence before meeting Dr. Zorn in January 2024 about the pros and cons of various procedures. Additionally, I checked Dr. Zorn’s background, research work, and presentations at different conferences, including the American Urological Association Annual Meeting. These convinced me that I am dealing with an exceptionally knowledgeable person with hands-on experience. I had aquablation procedure done in March 2024. Entered the facility at 12:30 p.m. as advised and got out of the facility at 7:30 p.m. with a catheter. The catheter was removed after 4 days. Pre-op and post-op teams are friendly and yet professional. For two weeks, had blood in my urine. For another week and a half, occasional blood clots (like rusted tiny, shredded papers) came out. Now, in my 5th week, the urine is clear like pristine water, and I pee like a young boy (as if a pinched tube has been opened). I was not surprised since Dr. Zorn explained these post-op events. Used to get up 5-6 times at night to go to the bathroom. Now it’s only twice and I drink water before going to bed. Understandably, sleep has improved. As a follow-up, I just met Dr. Zorn, and he said things would improve further (maybe waking up once at night for the bathroom) in the coming months. Let’s not forget we are aging human beings. The questions are: Is there a solution to the BPH problem, and whom should I consult with? If you believe in modern medical technology and would like to meet the best in the BPH mitigation procedure, I will humbly suggest Dr. Kevin Zorn.
Submitted April 25, 2024